Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 56 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Omega Therapeutics Inc | OMGA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.33 | 08:33:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.33 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 7 | 56 | - | 1.30 - 10.09 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:32:55 | 19 | $ 2.30 | USD |
Omega Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 128.48M | 55.14M | - | 3.09M | -97.43M | -1.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Omega Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OMGA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.57 | 2.57 | 2.26 | 2.38 | 292,146 | -0.24 | -9.34% |
| 1 Month | 3.60 | 3.77 | 2.26 | 2.82 | 346,298 | -1.27 | -35.28% |
| 3 Months | 3.69 | 4.4599 | 2.26 | 3.56 | 416,594 | -1.36 | -36.86% |
| 6 Months | 1.60 | 6.30 | 1.30 | 4.59 | 1,223,876 | 0.73 | 45.63% |
| 1 Year | 8.05 | 10.09 | 1.30 | 4.63 | 691,097 | -5.72 | -71.06% |
| 3 Years | 22.10 | 31.41 | 1.30 | 5.65 | 321,324 | -19.77 | -89.46% |
| 5 Years | 22.10 | 31.41 | 1.30 | 5.65 | 321,324 | -19.77 | -89.46% |
Omega Therapeutics Description
| Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease. |
